Jaguar Health, Inc. current report, 18 August 2015

Jaguar Health, Inc. Form 8-K Summary

Business Context and Reporting Period

This Current Report (Form 8-K) was filed by Jaguar Animal Health, Inc. on August 18, 2015. The filing discloses the entry into a Material Definitive Agreement and the creation of a direct financial obligation.

Key Financial Metrics and Obligations

  • Debt Facility: Entered into a senior secured term loan facility with a total capacity of up to $8,000,000.
  • Initial Draw: $6,000,000 was drawn on August 18, 2015.
  • Contingent Availability: An additional $2,000,000 is available at the Company's option contingent on satisfying specific milestones.
  • Interest Rate: Calculated at the greater of (i) 9.90% plus the prime rate minus 4.25%, or (ii) 9.90%.
  • Maturity: Initial term of approximately 36 months, maturing on August 1, 2018.
  • Repayment Terms: Interest-only period through February 29, 2016, followed by amortized principal and interest payments.
  • End of Term Payment: A required payment of $560,000 is due at the end of the term.
  • Collateral: The facility is secured by certain tangible and intangible personal property of the Company.

Material Changes and Covenants

The filing details significant new debt obligations and restrictive covenants not present in prior periods:

  • Minimum Cash Covenant: The Company must maintain a minimum cash balance of $4,500,000. This requirement may decrease to $3,000,000 upon achieving certain conditions, decrease further by the amount of amortization payments made, or be eliminated entirely upon achieving other specified conditions.
  • Extension Option: The Company may extend the maturity date to February 1, 2019, and the interest-only period to August 31, 2016, subject to satisfying performance milestones and electing to borrow the additional $2,000,000.
  • Prepayment Charges:
    • Prepayment within the first 12 months: 2.00% of the required minimum cash balance plus 3.00% of the prepaid amount in excess of that balance (if subject to the cash covenant); or 3.00% of the prepaid amount (if not subject to the cash covenant).
    • Prepayment after 12 months: 1.00% of the amount being prepaid.

Outlook, Risks, and Contingencies

The filing does not provide specific revenue guidance or management commentary on future operating performance. However, it outlines significant financial risks:

  • Events of Default: The agreement includes customary events of default. Upon an event of default, the lender (Hercules Technology Growth Capital, Inc.) may accelerate the debt, demanding immediate payment of all secured obligations plus prepayment charges.
  • Liquidity Constraints: The mandatory minimum cash balance of $4,500,000 restricts the Company's ability to deploy cash for operations or other purposes unless milestones are met to reduce or eliminate this requirement.

Investor Verification Checklist

  • Verify the Company's current cash balance against the $4,500,000 minimum covenant requirement.
  • Review the specific performance milestones required to unlock the additional $2,000,000 funding and to reduce or eliminate the minimum cash balance.
  • Assess the impact of the interest-only period ending in February 2016 on future cash flow requirements.
  • Confirm the status of the collateral pledged against the loan facility.
  • Examine the full text of the Loan and Security Agreement (Exhibit 10.1) for detailed definitions of "Events of Default" and specific milestone criteria.